Source link : https://newshealth.biz/health-news/fda-extends-roflumilasts-ad-approval-to-young-children/
The approval is for children ages 2-5 with mild-to-moderate atopic dermatitis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-extends-topical-roflumilasts-atopic-dermatitis-approval-2025a1000quo?src=rss Author : Publish date : 2025-10-06 20:11:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Extends Roflumilast’s AD Approval to Young Children first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-06 20:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8